CCRS to Start study on prophylactic use of Siddha in treating COVID-19 cases Kumar Jeetendra | June 29, 2020 Chennai, June 29 (PTI) Using a Siddha”addition” treatment to allopathic therapy in a government COVID-19 care facility giving encouraging results, the Central Council for Research at Siddha (CCRS) will shortly start a research on 60 coronavirus patients in Vysarpadi in town. The new clinical trial aims to bring the effectiveness of this Siddha group of …
India’s first COVID-19 immunization ‘COVAXIN’ by Bharat Biotech gets DCGI endorsement for human trial Kumar Jeetendra | June 30, 2020 India’s very first vaccine candidate against the novel coronavirus, COVAXIN, has received a nod in the Drug Controller General of India (DCGI) for further clinical trials Stage I and two in infected men and women. The vaccine is under development by Hyderbad-based biotechnology firm Bharat Biotech in cooperation with the Indian Council of Medical Research …
AstraZeneca says Brazil near coronavirus vaccine Bargain for 100 mn Dosages Kumar Jeetendra | June 30, 2020 Two days after Brazil’s government declared a contract with Oxford University and pharmaceutical company AstraZeneca to get up to 100 million doses of a promising coronavirus vaccine, a manager of the company stated the document was actually a letter of purpose and there continue to be crucial items to be negotiated. AstraZeneca manager Jorge Mazzei …
Indonesia looking for its own COVID-19 immunization in the midst of stress over access Kumar Jeetendra | July 2, 2020 Indonesia has been operating to produce its COVID-19 vaccine following year, thanks to growing anxiety that developing nations could have trouble getting access to a future jab, the head of Indonesia’s national COVID-19 research staff said Thursday. “The production capability and ability of biotech businesses in the world is, we understand, limited, and global supply …
ICMR affirms Covaxin dispatch likely by August 15, clinical preliminaries optimized Kumar Jeetendra | July 3, 2020 An ICMR representative has affirmed the credibility of a letter by ICMR Head that said the antibody preliminaries for Hyderabad-based Bharat Biotech’s COVID-19 immunization Covaxin have been optimized and that it could be propelled most recent by August 15. ICMR had on July 2 purportedly asked Bharat Biotech in an inner correspondence to quick track …
Researchers find little proteins which may lessen aggravation brought about by COVID-19 Kumar Jeetendra | July 5, 2020 Researchers have found a new drug which they claim could possibly be practical to combat inflammation of all varieties, an improvement that might help in fighting aggravated immune response in respiratory disorders like COVID-19. The therapeutic, described at the journal Cell Tales, is known as TAT CARMIL1, and it’s actually a combination of two naturally …
China’s Sinovac begins late stage preliminaries for its COVID-19 antibody Kumar Jeetendra | July 7, 2020 China’s Sinovac Biotech is starting Phase III trials of its potential coronavirus vaccine in Brazil, ” said on Monday, becoming among three companies to transfer to the late stages at the race to develop an inoculation against the disorder. It follows a fast-track approval for the trials by Brazilian labs last week. Sinovac stated the …
Baxter India gets CDSCO gesture for utilization of its Oxiris channel in COVID-19 treatment Kumar Jeetendra | July 7, 2020 Healthcare firm Baxter India on Tuesday said it has received consent from the Central Drugs Standard Control Organisation (CDSCO) for the usage of its Oxiris blood purification filter to the treatment of COVID-19 patients. The filter is meant to be utilised in the seriously ill COVID-19 patients needing blood purification where excess inflammatory mediators are …
Moderna competes with US researchers over COVID-19 antibody preliminaries Kumar Jeetendra | July 7, 2020 As america hastens the search to get a coronavirus vaccine, tensions have escalated between government scientists and Moderna Inc, among the leading programmers, Reuters has heard. The national government is supporting Moderna’s vaccine job by almost half a billion dollars and it has chosen it as one of the earliest to get into large-scale human …
Coronavirus fools the body into assaulting mind; normal indigestion drugs connected to COVID-19 hazard Kumar Jeetendra | July 10, 2020 This is a brief roundup of some of the most recent scientific research on the book coronavirus and attempts to locate vaccines and treatments like COVID-19, the disease brought on by the virus. Coronavirus tricks your system to attacking the mind Various neurological issues like tremors, seizures, along with diminished comprehension have been associated with …
Indoor airborne spread of virus possible: WHO Kumar Jeetendra | July 10, 2020 The World Health Organisation (WHO) has declared that the risk that the book coronavirus, which induces COVID-19, could be dispersed in the atmosphere under specific conditions — after over 200 scientists urged the bureau to achieve that. In an open letter released this week in a diary, two scientists in Australia and the US composed …
Oxford Covid antibody beginning phase preliminary shows promise Kumar Jeetendra | July 17, 2020 London, A Covid-19 vaccine manufactured by researchers at Oxford University generated an immune response from the disease in Phase-1 trial,” The Telegraph reported even as official book of those answers are awaited. Even the Oxford vaccine candidate is believed to be contributing the race among over 100 to obtain a successful protection against the disorder. …
